CRISPR Therapeutics
CRSP
#2966
Rank
A$6.69 B
Marketcap
$78.39
Share price
-0.50%
Change (1 day)
-2.04%
Change (1 year)

CRISPR Therapeutics (CRSP) Fails to deliver data

Key failure to deliver metrics for CRISPR Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016

Volume in USD (price x number of shares), data since 2016

CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.12 B-16.8%
2023A$0.14 B1.4%
2022A$0.14 B8.89%
2021A$0.13 B22.76%
2020A$0.10 B-2.51%
2019A$0.11 B59.97%
2018A$70.19 M265.26%
2017A$19.21 M319.28%
2016A$4.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1.42 MA$6.01 M๐Ÿ‡บ๐Ÿ‡ธ USA